Furqaan Ahmed

A Randomized Trial of Pegylated Interferon alpha-2b Plus Ribavirin in the Retreatment of Chronic Hepatitis C

Ira M. Jacobson, Stevan A. Gonzalez, Furqaan Ahmed et al. · The American Journal of Gastroenterology · 2005 · 139 citations

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16

A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms

Han‐Mo Chiu, Jessica Ching, Kaichun Wu et al. · Gastroenterology · 2015 · 103 citations

Medicine, Immunology, Oncology +17

Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT

Ira M. Jacobson, Furqaan Ahmed, Mark W. Russo et al. · The American Journal of Gastroenterology · 2004 · 43 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions

Martin C. S. Wong, Jessica Y. L. Ching, Han‐Mo Chiu et al. · The American Journal of Gastroenterology · 2016 · 30 citations

Medicine, Biostatistics, Oncology +17

Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers: Final results

Ira M. Jacobson, Furqaan Ahmed, Mark W. Russo et al. · Gastroenterology · 2003 · 29 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16